Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
43,483,337
-
Total 13F shares
-
44,848,348
-
Share change
-
+3,574,465
-
Total reported value
-
$652,883,600
-
Price per share
-
$14.56
-
Number of holders
-
114
-
Value change
-
+$53,846,942
-
Number of buys
-
63
-
Number of sells
-
40
Institutional Holders of Beta Bionics, Inc. - Common Stock (BBNX) as of Q2 2025
As of 30 Jun 2025,
Beta Bionics, Inc. - Common Stock (BBNX) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,848,348 shares.
The largest 10 holders included
EVENTIDE ASSET MANAGEMENT, LLC, FARALLON CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, Soleus Capital Management, L.P., Sands Capital Alternatives, LLC, RTW INVESTMENTS, LP, MORGAN STANLEY, Omega Fund Management, LLC, PERCEPTIVE ADVISORS LLC, and DEERFIELD MANAGEMENT COMPANY, L.P..
This page lists
114
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.